A detailed history of Waldron Private Wealth LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Waldron Private Wealth LLC holds 30,537 shares of MRK stock, worth $2.92 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
30,537
Previous 31,257 2.3%
Holding current value
$2.92 Million
Previous $3.55 Million 14.43%
% of portfolio
0.12%
Previous 0.15%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

SELL
$96.31 - $114.76 $69,343 - $82,627
-720 Reduced 2.3%
30,537 $3.04 Million
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $3,667 - $4,256
-33 Reduced 0.11%
31,257 $3.55 Million
Q2 2024

Jul 31, 2024

SELL
$123.8 - $132.96 $10,894 - $11,700
-88 Reduced 0.28%
31,290 $3.87 Million
Q1 2024

May 09, 2024

BUY
$113.24 - $131.95 $178,692 - $208,217
1,578 Added 5.3%
31,378 $4.14 Million
Q4 2023

Aug 29, 2024

SELL
$100.18 - $109.02 $869,161 - $945,857
-8,676 Reduced 22.55%
29,800 $3.25 Million
Q4 2023

Jan 30, 2024

SELL
$100.18 - $109.02 $869,161 - $945,857
-8,676 Reduced 22.55%
29,800 $3.27 Million
Q3 2023

Aug 29, 2024

SELL
$102.95 - $114.33 $85,036 - $94,436
-826 Reduced 2.1%
38,476 $3.96 Million
Q3 2023

Oct 26, 2023

SELL
$102.95 - $114.33 $85,036 - $94,436
-826 Reduced 2.1%
38,476 $3.99 Million
Q2 2023

Aug 29, 2024

SELL
$108.61 - $118.38 $96,988 - $105,713
-893 Reduced 2.22%
39,302 $4.54 Million
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $96,988 - $105,713
-893 Reduced 2.22%
39,302 $4.56 Million
Q1 2023

Aug 29, 2024

BUY
$102.94 - $114.86 $916,680 - $1.02 Million
8,905 Added 28.46%
40,195 $4.28 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $433,480 - $483,675
4,211 Added 11.7%
40,195 $4.31 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $84,445 - $94,865
999 Added 2.86%
35,984 $3.12 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $88,916 - $100,791
1,065 Added 3.14%
34,985 $3.21 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $63,806 - $71,523
868 Added 2.63%
33,920 $2.81 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $142,463 - $178,454
1,971 Added 6.34%
33,052 $2.56 Million
Q3 2021

Nov 02, 2021

BUY
$71.68 - $78.83 $163,645 - $179,968
2,283 Added 7.93%
31,081 $2.35 Million
Q2 2021

Aug 06, 2021

BUY
$70.31 - $77.77 $173,665 - $192,091
2,470 Added 9.38%
28,798 $2.26 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $70,650 - $83,218
1,026 Added 4.06%
26,328 $2.05 Million
Q4 2020

Feb 12, 2021

SELL
$71.77 - $79.65 $54,114 - $60,056
-754 Reduced 2.89%
25,302 $2.09 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $95,060 - $107,752
1,299 Added 5.25%
26,056 $2.18 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $24,576 - $27,965
349 Added 1.43%
24,757 $1.93 Million
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $595,837 - $825,859
9,404 Added 62.68%
24,408 $1.89 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $8,999 - $10,154
-116 Reduced 0.77%
15,004 $1.37 Million
Q3 2019

Nov 06, 2019

BUY
$76.08 - $82.93 $8,673 - $9,454
114 Added 0.76%
15,120 $1.28 Million
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $50,284 - $58,744
-720 Reduced 4.58%
15,006 $1.27 Million
Q1 2019

May 01, 2019

BUY
$69.58 - $79.36 $173,532 - $197,923
2,494 Added 18.85%
15,726 $1.32 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $280,336 - $325,325
4,297 Added 48.09%
13,232 $1.01 Million
Q3 2018

Nov 20, 2018

BUY
$57.69 - $67.84 $172,146 - $202,434
2,984 Added 50.14%
8,935 $633,000
Q2 2018

Aug 09, 2018

SELL
$50.83 - $59.72 $115,180 - $135,325
-2,266 Reduced 27.58%
5,951 $361,000
Q1 2018

May 09, 2018

BUY
$50.96 - $59.23 $6,471 - $7,522
127 Added 1.57%
8,217 $447,000
Q4 2017

Jan 26, 2018

BUY
$51.62 - $61.64 $7,743 - $9,246
150 Added 1.89%
8,090 $455,000
Q3 2017

Nov 08, 2017

BUY
$58.67 - $63.13 $3,813 - $4,103
65 Added 0.83%
7,940 $508,000
Q2 2017

Aug 14, 2017

BUY
N/A
7,875
7,875 $504,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.